920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients

BACKGROUND: Norovirus (NoV) results in potentially severe, relapsing, remitting diarrhea in immunocompromised hosts (ICH). A number of interventions, including nitazoxanide (NTZ), have been tried with unclear success in managing cases of NoV in ICH. METHODS: We conducted a NIH-sponsored multi-center...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutin, Catherine-Audrey, Callegari, Michelle A, Florescu, Diana F, Nguyen, Minh-Hong, Kaul, Daniel, Avery, Robin K, Chong, Pearlie P, Fisher, Cynthia E, Limaye, Ajit, Clough, Lisa A, Pergam, Steven A, Green, Michael D, Michaels, Marian G, Danziger-Isakov, Lara A, Angarone, Michael P, Keefer, Laurie, Daud, Amna, Ison, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677881/
http://dx.doi.org/10.1093/ofid/ofad500.965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677881/
http://dx.doi.org/10.1093/ofid/ofad500.965

Ejemplares similares